Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment
Sjogren's syndrome: An update on disease pathogenesis, clinical manifestations and treatment …

Interstitial lung disease (ILD) is considered the most frequent and serious pulmonary
complication in primary Sjögren's syndrome (pSS), with the majority of the studies indicating …

Background Interstitial lung disease (ILD) may cause life-threatening complications of
primary Sjogren's syndrome (pSS), and has a poor prognosis in terms of survival and quality …

OBJECTIVES: To analyse the frequency and characterise the systemic presentation of
primary Sjögren's syndrome (SS) out of the ESSDAI classification in a large international …

Pulmonary involvement in primary Sjögren's syndrome (pSS) is an understudied entity with
important clinical implications. Its prevalence has been reported in up to 20% of pSS …

Interstitial lung disease (ILD) is a relatively frequent manifestation of systemic autoimmune
rheumatic disorders (SARDs), including systemic sclerosis (SSc), rheumatoid arthritis (RA) …

Interstitial lung disease (ILD) is a collective term representing a diverse group of pulmonary
fibrotic and inflammatory conditions. Due to the diversity of ILD conditions, paucity of …

Background: Pulmonary lung involvement is the most common extra-glandular manifestation
in patients with primary Sjögren's syndrome (pSS), leading to a worsening of the patient's …

Objective To systematically review the prevalence and risk factors for interstitial lung disease
(ILD) in patients with primary Sjögren's syndrome (pSS). Methods We searched PubMed …

Objective To investigate characteristics of patients with primary Sjögren's syndrome (pSS)-
associated interstitial lung disease (ILD) and relevant features of ILD progression. Method …